Literature DB >> 3533331

Class II antigens in Hashimoto thyroiditis. I. Synthesis and expression of HLA-DR and HLA-DQ by thyroid epithelial cells.

J Möst, W Knapp, G Wick.   

Abstract

Aberrant expression of HLA-DR antigens on epithelial cells is seen in various organ-specific autoimmune disorders including Hashimoto thyroiditis (HT). Expression of HLA-DQ has so far not been demonstrated on these cells. We report here that thyroid epithelial cells (TEC) in HT, in addition to the known aberrant expression of HLA-DR, coexpress HLA-DQ antigens. Furthermore we provide evidence that class II antigens are synthesized by TEC themselves by demonstration of intracellular HLA-DR gamma-chain. These findings support the theory that TEC may be able to present (auto)antigens in vivo thus perhaps contributing to the perpetuation of thyroid destruction. As expression of class II antigens on TEC was never observed in non- or weakly infiltrated areas, we propose that infiltration by T cells is necessary to induce this aberrant expression of class II antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533331     DOI: 10.1016/0090-1229(86)90100-5

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  10 in total

1.  Expression of HLA-DR antigen on hepatic vascular endothelial cells in idiopathic portal hypertension.

Authors:  T Terada; Y Nakanuma; M Hoso; H Obata
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

2.  Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.

Authors:  F Momburg; K Koretz; A Von Herbay; P Möller
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

3.  Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease.

Authors:  K Koretz; F Momburg; H F Otto; P Möller
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

4.  HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.

Authors:  G Ballardini; F B Bianchi; R Mirakian; M Fallani; E Pisi; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

5.  HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro.

Authors:  I Todd; R Pujol-Borrell; B A Abdul-Karim; L J Hammond; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

6.  Increased epithelial expression of HLA-DQ and HLA-DP molecules in salivary glands from patients with Sjögren's syndrome compared with obstructive sialadenitis.

Authors:  P S Thrane; T S Halstensen; H R Haanaes; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

7.  Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma.

Authors:  J M Liversidge; H F Sewell; J V Forrester
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

8.  Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.

Authors:  T Degener; F Momburg; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

9.  Lymphokine-induced MHC class II antigen expression on cultured retinal pigment epithelial cells and the influence of cyclosporin A.

Authors:  J Liversidge; H F Sewell; A W Thomson; J V Forrester
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

Review 10.  Molecular Insights Into the Relationship Between Autoimmune Thyroid Diseases and Breast Cancer: A Critical Perspective on Autoimmunity and ER Stress.

Authors:  Safikur Rahman; Ayyagari Archana; Arif Tasleem Jan; Durgashree Dutta; Abhishek Shankar; Jihoe Kim; Rinki Minakshi
Journal:  Front Immunol       Date:  2019-03-01       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.